Mutant ASXL1 is frequently present in different myeloid malignancies, namely MDS, myeloproliferative neoplasms (MPNs), MDS/ MPNs, and primary and secondary AML. This evidence concerns the gene ASXL1 and myelodysplastic syndrome.